Le Lézard
Classified in: Health
Subject: SVY

Brazil Spinal Implants and VCF Market 2018-2024: Units Sold, Average Selling Prices, Procedure Volumes, Market Values, Shares, Product Pipeline & Forecasts


DUBLIN, July 18, 2018 /PRNewswire/ --

The "Spinal Implants and VCF Market | Brazil | Units Sold, Average Selling Prices, Procedure Volumes, Market Values, Shares, Product Pipeline, Forecasts, SWOT | 2018-2024 | MedSuite" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

A major limiting factor for the traditional spinal fusion markets is the development of motion preservation technology. Lumbar artificial discs (LADs) have not been as successful at cannibalizing thoracolumbar fixation devices as previously anticipated due to a lack of reimbursement and unfavorable clinical results.

Favorable reimbursement policies are expected for these devices as favorable clinical results involving newer devices emerge. Despite many challenges, growth is expected in many market segments, as the patient demographics and rising incomes in Brazil maintain a steady demand for such procedures.

Barring unexpected major demographic change, for the next three to five decades the speed of aging in the region will continue on a singularly rapid course. Growth in the number of persons aged 60 and over is expected to stimulate growth in both fusion and non-fusion spinal implant markets.

Key Topics Covered:

Executive Summary
Brazil Spinal Implants And Vcf Market Overview
Competitive Analysis
Market Trends
Market Developments
Markets Included
Key Report Updates
Version History

1. Research Methodology

2. Brazil Spinal Implants And Vcf Market Overview
2.1 Introduction
2.2 Currency Exchange Rate
2.3 Market Overview
2.4 Trend Analysis By Segment
2.5 Drivers And Limiters
2.5.1 Market Drivers
2.5.2 Market Limiters
2.6 Competitive Market Share Analysis

3. Procedure Numbers
3.1 Introduction
3.2 Procedure Numbers
3.2.1 Cervical Fixation Procedures
3.2.1.1 Anterior Cervical Fixation Procedures
3.2.1.1.1 Constrained Anterior Cervical Fixation Procedures
3.2.1.1.2 Semi-Constrained Anterior Cervical Fixation Procedures
3.2.1.1.3 Dynamic Anterior Cervical Fixation Procedures
3.2.1.1.4 Bioresorbable Anterior Cervical Fixation Procedures
3.2.1.2 Posterior Cervical Fixation Procedures
3.2.1.2.1 Cable/Wiring Posterior Cervical Fixation Procedures
3.2.1.2.2 Screw/Rod Posterior Cervical Fixation Procedures
3.2.1.2.3 Occipitocervical Posterior Cervical Fixation Procedures
3.2.2 Thoracolumbar Fixation Procedures
3.2.2.1 Degenerative Thoracolumbar Fixation Procedures
3.2.2.1.1 Anterior Plating Procedures
3.2.2.1.2 Posterior Fixation Procedures
3.2.2.1.3 Degenerative Thoracolumbar Fixation Procedures By Levels Treated
3.2.2.2 Deformity Correction Thoracolumbar Fixation Procedures
3.2.2.3 Trauma/Tumor Thoracolumbar Fixation Procedures
3.2.3 Interbody Device Procedures
3.2.3.1 Alif Procedures
3.2.3.1.1 Metal Alif Procedures
3.2.3.1.2 Peek Alif Procedures
3.2.3.1.3 Machined Bone Alif Procedures
3.2.3.2 Plif Procedures
3.2.3.2.1 Metal Plif Procedures
3.2.3.2.2 Peek Alif Procedures
3.2.3.2.3 Machined Bone Alif Procedures
3.2.3.3 Tlif Procedures
3.2.3.3.1 Metal Tlif Procedures
3.2.3.3.2 Peek Tlif Procedures
3.2.3.3.3 Machined Bone Tlif Procedures
3.2.3.4 Cif Procedures
3.2.3.4.1 Metal Cif Procedures
3.2.3.4.2 Peek Cif Procedures
3.2.3.4.3 Machined Bone Cif Procedures
3.2.3.5 Vbr/Corpectomy Procedures
3.2.3.5.1 Metal Vbr/Corpectomy Procedures
3.2.3.5.2 Peek Vbr/Corpectomy Procedures
3.2.3.6 Expandable Interbody Procedures
3.2.3.6.1 Metal Expandable Interbody Procedures
3.2.3.6.2 Peek Expandable Interbody Procedures
3.2.3.7 Peek Standalone Interbody Procedures
3.2.3.8 Procedures By Material
3.2.3.8.1 Metal Interbody Procedures
3.2.3.8.2 Peek Interbody Procedures
3.2.3.8.3 Machined Bone Interbody Procedures
3.2.4 Motion Preservation Device Procedures
3.2.4.1 Artificial Disc Procedures
3.2.4.2 Dynamic Stabilization Device Procedures
3.2.5 Vertebral Compression Fracture Procedures
3.2.5.1 Vertebroplasty Procedures
3.2.5.2 Percutaneous Vertebral Augmentation Procedures
3.2.6 Spinal Electrical Stimulation Device Procedures

4. Cervical Fixation Market
4.1 Introduction
4.2 Market Overview
4.3 Market Analysis And Forecast
4.3.1 Total Cervical Fixation Market
4.3.2 Anterior Cervical Fixation Market
4.3.3 Posterior Cervical Fixation Market
4.4 Drivers And Limiters
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 Competitive Market Share Analysis

5. Thoracolumbar Fixation Market
5.1 Introduction
5.2 Market Overview
5.3 Market Analysis And Forecast
5.3.1 Degenerative Thoracolumbar Fixation Market By Approach
5.3.1.1 Anterior Plating Market
5.3.1.2 Posterior Fixation Market
5.3.2 Deformity Correction Thoracolumbar Fixation Market
5.3.3 Trauma/Tumor Thoracolumbar Fixation Market
5.4 Drivers And Limiters
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 Competitive Market Share Analysis

6. Interbody Device Market
6.1 Introduction
6.2 Market Overview
6.3 Market Analysis And Forecast
6.3.1 Total Interbody Device Market
6.3.2 Alif Market
6.3.3 Plif Market
6.3.4 Tlif Market
6.3.5 Cif Market
6.3.6 Vbr/Corpectomy Market
6.3.7 Expandable Interbody Device Market
6.3.8 Standalone Interbody Device Market
6.4 Unit Analysis And Forecast
6.5 Drivers And Limiters
6.5.1 Market Drivers
6.5.2 Market Limiters
6.6 Competitive Market Share Analysis

7. Motion Preservation Devices Market
7.1 Introduction
7.2 Market Overview
7.3 Market Analysis And Forecast
7.3.1 Artificial Disc Market By Segment
7.3.1.1 Cervical Artificial Disc Market
7.3.1.2 Lumbar Artificial Disc Market
7.3.2 Dynamic Stabilization Device Market By Segment
7.3.2.1 Dynamic Posterior Stabilization Device Market
7.3.2.2 Interspinous Process Decompression Device Market
7.4 Drivers And Limiters
7.4.1 Market Drivers
7.4.2 Market Limiters
7.5 Competitive Market Share Analysis

8. Vertebral Compression Fracture Market
8.1 Introduction
8.2 Market Overview
8.3 Market Analysis And Forecast
8.3.1 Total Vertebral Compression Fracture Market
8.3.2 Vertebroplasty Market
8.3.3 Percutaneous Vertebral Augmentation Market
8.4 Drivers And Limiters
8.4.1 Market Drivers
8.4.2 Market Limiters
8.5 Competitive Market Share Analysis

9. Spinal Electrical Stimulation Device Market
9.1 Introduction
9.2 Market Overview
9.3 Market Analysis And Forecast
9.3.1 Total Spinal Electrical Stimulation Device Market
9.3.2 Cervical Spinal Electrical Stimulation Device Market
9.3.3 Lumbar Spinal Electrical Stimulation Device Market
9.4 Drivers And Limiters
9.4.1 Market Drivers
9.4.2 Market Limiters
9.5 Competitive Market Share Analysis

10. Spinal Surgery Instrumentation Market
10.1 Introduction
10.2 Market Analysis And Forecast
10.3 Drivers And Limiters
10.3.1 Market Drivers
10.3.2 Market Limiters
10.4 Competitive Market Share Analysis

11. Abbreviations 

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/research/kxpwm4/brazil_spinal?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: